Bortezomib-Induced Epstein–Barr Virus and Kaposi Sarcoma Herpesvirus Lytic Gene Expression

Current Opinion in Oncology - United States
doi 10.1097/cco.0b013e3283499c37
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Epstein–Barr Virus Enhances Genome Maintenance of Kaposi Sarcoma-Associated Herpesvirus

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Latency and Lytic Replication in Epstein–Barr Virus-Associated Oncogenesis

Nature Reviews Microbiology
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2019English

Unexpected Structure of Epstein–Barr Virus Lytic Cycle Activator Zta

Trends in Microbiology
VirologyInfectious DiseasesMicrobiology
2006English

Kaposi Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 and Lymphoproliferative Disorders

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Zidovudine-Based Lytic-Inducing Chemotherapy for Epstein–Barr Virus-Related Lymphomas

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

A Cancer-Associated Epstein-Barr Virus BZLF1 Promoter Variant Enhances Lytic Infection

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2018English

Essential Role of Rta in Lytic DNA Replication of Epstein-Barr Virus

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2012English

Identification and Characterization of the Physiological Gene Targets of the Essential Lytic Replicative Epstein-Barr Virus SM Protein

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

TRIM5α Promotes Ubiquitination of Rta From Epstein–Barr Virus to Attenuate Lytic Progression

Frontiers in Microbiology
Microbiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy